Clinical trial
Tandem High Dose Melphalan Versus Triple Intermediate Dose Melphalan and Stem…
NCT00205764 · Austrian Forum Against Cancer, Other · Completed
Key facts
| NCT number | NCT00205764 |
|---|---|
| Title | Tandem High Dose Melphalan Versus Triple Intermediate Dose Melphalan and Stem Cell Transplantation in Induction Phase and Prednisolone/IFN Versus IFN in Maintenance Therapy |
| Official title | Randomised, Non-blind, Parallel Group Study to Compare Tandem High Dose Melphalan (200mg/m²) Versus Triple Intermediate Dose Melphalan (100mg/m²) and Stem Cell Transplantation in Induction Phase and Prednisolone/IFN Versus IFN in Maintenance Therapy in Newly Diagnosed Patients With Multiple Myeloma |
| Lead sponsor | Austrian Forum Against Cancer, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Multiple Myeloma |
| Intervention type | Drug |
| Interventions | Melphalan |
| Enrollment | 212 |
| Start date | Mar 1, 1999 |
| Completion | Oct 1, 2009 |
| First posted | Sep 20, 2005 |
| Last update posted | Nov 25, 2013 |
| Countries | Austria |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: